NeuClone

Overview
News
Biosimilars?
Product stageSegments
Seed
?
Pure Play Biosimilars Developers
?

NeuClone is a biopharmaceutical company focused on developing biosimilar medications. The company's primary efforts are directed toward creating biosimilars of established drugs to increase patient access to important treatments. NeuClone's pipeline includes biosimilar candidates for several well-known medications, including Stelara (ustekinumab), Herceptin (trastuzumab), Opdivo (nivolumab), and Keytruda (pembrolizumab). The company has made significant progress in its clinical trials, particularly with its Stelara biosimilar candidate. In October 2020, NeuClone announced positive results from a Phase I study of this ustekinumab biosimilar. The company completed subject visits for this Phase I clinical trial in April 2020, following the completion of dosing in December 2019. NeuClone also reported positive results from a Phase I study of its Herceptin biosimilar candidate in December 2019. These developments demonstrate the company's commitment to advancing its biosimilar portfolio through rigorous clinical testing.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
Australian Technology Park, National Innovation Centre 4 Cornwallis Street Eveleigh Sydney AUS
Founded year:
2007
Employees:
-
IPO status:
Private
Total funding:
-
Last Funding:
-
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.